Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

Q: What does CUSIP 28036F105 represent in this 13F holders report?

CUSIP 28036F105 is the security identifier for EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q1 2026?

5 institutional investors reported EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 28036F105

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 105,503,387
Total 13F shares: 3,615
Share change: +921
Total reported value: $114,932
Price per share: $31.50
Number of holders: 5
Value change: +$28,989
Number of buys: 1
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 28036F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F 13D/G 3/4/5	Company · Director, 10%+ Owner	14% from 13D/G	15,518,492	$385,091,379	—	31 Dec 2025	13F 13D/G 3/4/5
RA CAPITAL MANAGEMENT, L.P.	13F 13D/G	Company	9.9% from 13D/G	10,428,437	$258,781,664	—	31 Dec 2025	13F 13D/G
BlackRock, Inc.	13F 13D/G	Company	5.5% from 13D/G	6,630,576	$164,537,741	—	31 Dec 2025	13F 13D/G
BAKER BROS. ADVISORS LP	13F 13D/G	Company	6.9% from 13D/G	6,575,940	$163,181,951	—	31 Dec 2025	13F 13D/G
Paradigm Biocapital Advisors LP	13F 13D/G	Company	6.2% from 13D/G	6,541,210	$162,320,126	—	31 Dec 2025	13F 13D/G
Novo Holdings A/S	13F 3/4/5	Company · 10%+ Owner	5.1%	5,350,000	$132,760,250	—	31 Dec 2025	13F 3/4/5
BRAIDWELL LP	13F	Company	4.9%	5,210,831	$129,306,771	—	31 Dec 2025	13F
VANGUARD GROUP INC	13F	Company	4.6%	4,871,624	$120,889,349	—	31 Dec 2025	13F
JANUS HENDERSON GROUP PLC	13F 13D/G	Company	4.7% from 13D/G	4,566,850	$113,326,384	—	31 Dec 2025	13F 13D/G
Siren, L.L.C.	13F	Individual	4.3%	4,529,990	$112,411,702	—	31 Dec 2025	13F
PERCEPTIVE ADVISORS LLC	13F 13D/G	Company	4.4% from 13D/G	4,457,974	$110,624,625	—	31 Dec 2025	13F 13D/G
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	4%	4,191,193	$104,004,458	—	31 Dec 2025	13F
Cormorant Asset Management, LP	13F	Company	3.1%	3,285,000	$81,517,275	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	2.8%	2,910,881	$72,233,511	—	31 Dec 2025	13F
UBS Group AG	13F	Company	2%	2,117,073	$52,535,166	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.7%	1,746,222	$43,340,399	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	1.6%	1,717,343	$42,615,867	—	31 Dec 2025	13F
MPM BioImpact LLC	13F	Company	1.6%	1,655,256	$41,075,178	—	31 Dec 2025	13F
First Light Asset Management, LLC	13F	Company	1.5%	1,573,701	$39,051,392	—	31 Dec 2025	13F
Bellevue Group AG	13F	Company	1.4%	1,528,518	$37,930,174	—	31 Dec 2025	13F
Integral Health Asset Management, LLC	13F	Company	1.4%	1,500,000	$37,222,500	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.4%	1,474,797	$36,597,088	—	31 Dec 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.2%	1,213,657	$30,114,975	—	31 Dec 2025	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	1.1%	1,186,467	$29,442,210	—	31 Dec 2025	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.98%	1,036,170	$25,712,559	—	31 Dec 2025	13F
Soleus Capital Management, L.P.	13F	Company	0.86%	910,000	$22,581,650	—	31 Dec 2025	13F
Aberdeen Group plc	13F	Company	0.78%	821,940	$20,396,441	—	31 Dec 2025	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.73%	765,694	$19,000,697	—	31 Dec 2025	13F
NORGES BANK	13F	Company	0.71%	751,355	$18,644,874	—	31 Dec 2025	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.71%	746,562	$18,525,936	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.68%	718,372	$17,826,402	—	31 Dec 2025	13F
Artisan Partners Limited Partnership	13F	Company	0.67%	704,077	$17,471,671	—	31 Dec 2025	13F
FMR LLC	13F	Company	0.66%	692,955	$17,195,678	—	31 Dec 2025	13F
MARSHALL WACE, LLP	13F	Company	0.65%	681,921	$16,925,279	—	31 Dec 2025	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.61%	640,400	$15,891,526	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.58%	611,384	$15,171,494	—	31 Dec 2025	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.54%	568,310	$14,102,613	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.53%	559,649	$13,887,690	—	31 Dec 2025	13F
S.c.a. Candriam	13F	Individual	0.48%	501,214	$12,438,155	—	31 Dec 2025	13F
Opaleye Management Inc.	13F	Company	0.47%	500,000	$12,407,500	—	31 Dec 2025	13F
Sofinnova Investments, Inc.	13F	Company	0.41%	437,819	$10,864,478	—	31 Dec 2025	13F
Parkman Healthcare Partners LLC	13F	Company	0.41%	427,690	$10,613,127	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	0.37%	394,695	$9,794,356	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.35%	372,738	$9,249,495	—	31 Dec 2025	13F
STEMPOINT CAPITAL LP	13F	Company	0.34%	360,876	$8,955,138	—	31 Dec 2025	13F
Peter A. Thompson	3/4/5	Director, 10%+ Owner	— mixed-class rows	473,792 mixed-class rows	$8,933,533	—	16 Jun 2025	3/4/5
Squadron Capital Management LLC	13F	Company	0.33%	350,000	$8,685,250	—	31 Dec 2025	13F
Eversept Partners, LP	13F	Company	0.32%	337,340	$8,371,092	—	31 Dec 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.28%	296,208	$7,350,402	—	31 Dec 2025	13F
Universal- Beteiligungs- und Servicegesellschaft mbH	13F	Individual	0.26%	271,385	$6,734,419	—	31 Dec 2025	13F

Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) as of Q1 2026

As of 31 Mar 2026, Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,615 shares. The largest 5 holders included GAMMA Investing LLC, Farther Finance Advisors, LLC, SIGNATUREFD, LLC, EASTERN BANK, and Versant Capital Management, Inc. This page lists 5 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

197

Q1 2026 holders

Holder diff

-192

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.